Stonegate Initiates Coverage on Incannex Healthcare Inc. (NasdaqGM:IXHL)

Article

Paid press release content from Reportable. The StreetInsider.com news staff was not involved in its creation.

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI

6. ROST
7. BILL
8. MRK
9. MRNA
10. COTY

Get Alerts IXHL Hot Sheet

Price: $3.62 +5.23%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

DALLAS, TX -- October 2nd, 2024 -- Incannex Healthcare Inc. (NasdaqGM:IXHL): Stonegate Capital Partners initiates their coverage on Incannex Healthcare Inc. (NasdaqGM:IXHL)

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

Advancing proprietary, synthetic first and best-in-class cannabinoid and psychedelic-assisted therapeutics
Conducting FDA phase 2/3 trial, IHL-42X, for the treatment of Obstructive Sleep Apnea (OSA)
IHL-42X pivotal phase 2 top-line data expected first half 2025

Click image above to view full announcement.

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.